10 Participants Needed

Portable Oxygen Concentrator for Obstructive Sleep Apnea

(DOSA Trial)

SH
Overseen BySuzie Hicks, BS
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Children's Hospital Medical Center, Cincinnati
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

Conducting a randomized control trial of oxygen in children with Down syndrome to treat moderate to severe obstructive sleep apnea. The aim of the study is to conduct a comparison between the 2 methods of oxygen delivery during sleep in 15 children from Cincinnati Children's Hospital and Children's Hospital of Los Angeles. 2 polysomnographies will be performed, one with continuous flow and the second with pulse flow.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Portable Oxygen Concentrator for Obstructive Sleep Apnea?

Research shows that using a portable oxygen concentrator with an auto-demand function can improve oxygen levels during sleep and reduce the number of breathing interruptions in people with obstructive sleep apnea. This suggests it may help improve sleep quality and reduce symptoms.12345

Is portable oxygen concentrator therapy generally safe for humans?

The research articles provided do not contain specific safety data on portable oxygen concentrators or related oxygen therapies for obstructive sleep apnea or other conditions.678910

How is the portable oxygen concentrator with demand oxygen delivery different from other treatments for obstructive sleep apnea?

The portable oxygen concentrator with demand oxygen delivery is unique because it automatically adjusts oxygen flow based on the user's breathing patterns, providing pulsed oxygen when it detects apnea (pauses in breathing), unlike traditional continuous-flow systems.12111213

Research Team

RA

Raouf Amin, MD

Principal Investigator

Children's Hospital Medical Center, Cincinnati

Eligibility Criteria

This trial is for children with Down syndrome at Cincinnati Children's Hospital and Children's Hospital of Los Angeles who have moderate to severe obstructive sleep apnea. Specific eligibility criteria are not provided, but typically participants must meet certain health standards and may be excluded based on factors that could impact the study or their safety.

Inclusion Criteria

Absence of clinically significant hypoxia defined as oxygen saturation < 88% for 5 minutes or episodic desaturation to 60%
I am between 5 and 17 years old, with or without Down Syndrome.
My child has moderate to severe sleep apnea.

Exclusion Criteria

Unable to participate in a Polysomnogram (PSG)
I use supplemental oxygen daily.
Current CPAP use with documented compliance (> 4 hrs/ night; > 70% of nights)
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive oxygen delivery through continuous flow and pulse flow during sleep, with 2 polysomnographies performed

6 months
2 visits (in-person) for polysomnographies

Follow-up

Participants are monitored for safety and effectiveness after treatment, including neurocognitive and cardiac outcomes

6 months

Treatment Details

Interventions

  • Demand Oxygen Delivery
Trial Overview The trial is testing a portable oxygen concentrator (Inogen G5 model) to treat obstructive sleep apnea in children with Down syndrome. It compares two methods of oxygen delivery during sleep: continuous flow versus pulse flow, using two separate polysomnographies.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Reducing the frequency of obstructive apnea (Main study)Experimental Treatment1 Intervention
The arm of the main study is still under development
Group II: Inogen portable oxygen concentrator unit versus continuous flow (Pilot Study)Experimental Treatment1 Intervention
The aim of this pilot study is to examine whether clinically important indices during sleep are comparable between oxygen delivery by portable and by continuous flow.

Demand Oxygen Delivery is already approved in United States for the following indications:

🇺🇸
Approved in United States as Oxygen Therapy for:
  • Obstructive Sleep Apnea in Children with Down Syndrome

Find a Clinic Near You

Who Is Running the Clinical Trial?

Children's Hospital Medical Center, Cincinnati

Lead Sponsor

Trials
844
Recruited
6,566,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Findings from Research

A study involving 20 patients with chronic obstructive pulmonary disease or interstitial pneumonia is testing a new portable oxygen concentrator with an auto-demand oxygen delivery system (auto-DODS) to see if it is as effective as a continuous-flow oxygen concentrator for improving oxygen levels during sleep.
The primary goal is to measure mean oxygen saturation during sleep, and if the auto-DODS proves to be non-inferior, it could simplify treatment by allowing patients to use one device for both day and night oxygen therapy.
Randomized cross-over trial of demand oxygen delivery system in nocturnal hypoxemia.Nagano, T., Kobayashi, K., Omori, T., et al.[2020]
A study involving 26 patients with chronic respiratory conditions will compare a new portable oxygen concentrator with auto-demand oxygen delivery system (auto-DODS) to a conventional system, focusing on its effectiveness in maintaining oxygen saturation during rest and exercise.
The primary goal is to assess mean oxygen saturation levels, while secondary measures will evaluate the device's operational efficiency, patient comfort, and overall reliability, providing insights into the potential benefits of the auto-DODS in improving patient outcomes.
Randomized cross-over trial of demand oxygen delivery system.Nagano, T., Kobayashi, K., Omori, T., et al.[2022]
In a study of 76 patients with obstructive sleep apnea, continuous positive airway pressure (CPAP) significantly improved sleep quality by increasing REM sleep and reducing light sleep, with effects noticeable from the first night of treatment.
CPAP also corrected respiratory issues and reduced arousal disturbances associated with OSA, while supplemental oxygen only improved oxygen saturation without enhancing overall sleep quality.
Effect of continuous positive airway pressure versus supplemental oxygen on sleep quality in obstructive sleep apnea: a placebo-CPAP-controlled study.Loredo, JS., Ancoli-Israel, S., Kim, EJ., et al.[2022]

References

Randomized cross-over trial of demand oxygen delivery system in nocturnal hypoxemia. [2020]
Randomized cross-over trial of demand oxygen delivery system. [2022]
Effect of continuous positive airway pressure versus supplemental oxygen on sleep quality in obstructive sleep apnea: a placebo-CPAP-controlled study. [2022]
Nocturnal oxygen enrichment in sleep apnoea. [2017]
Oxygen for the treatment of obstructive sleep apnoea hypopnoea syndrome. [2020]
A Decade of Difficult Airway Response Team: Lessons Learned from a Hospital-Wide Difficult Airway Response Team Program. [2019]
Incidents during out-of-hospital patient transportation. [2019]
Patient safety events in out-of-hospital paediatric airway management: a medical record review by the CSI-EMS. [2018]
Patient safety incidents associated with airway devices in critical care: a review of reports to the UK National Patient Safety Agency. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Airway management in the operating room setting: An analysis of reported safety events. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Performance comparison of 4 portable oxygen concentrators. [2010]
12.United Statespubmed.ncbi.nlm.nih.gov
The cost of breathing: an economic analysis of the patient cost of home oxygen therapy. [2017]
13.United Statespubmed.ncbi.nlm.nih.gov
Portable pulse-dose oxygen concentrators should not be used with noninvasive ventilation. [2013]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security